BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 27098676)

  • 21. The effect of direct referral for fast CT scan in early lung cancer detection in general practice. A clinical, cluster-randomised trial.
    Guldbrandt LM
    Dan Med J; 2015 Mar; 62(3):. PubMed ID: 25748876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of messaging informed by behavioural science on uptake of targeted lung health checks: a service evaluation.
    Salman M; Fernandez Crespo R; Judah G
    Lancet; 2023 Nov; 402 Suppl 1():S82. PubMed ID: 37997128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Case finding and therapy for chronic viral hepatitis in primary care (HepFREE): a cluster-randomised controlled trial.
    Flanagan S; Kunkel J; Appleby V; Eldridge SE; Ismail S; Moreea S; Griffiths C; Walton R; Pitt M; Salmon A; Madurasinghe V; Barnes E; Simms E; Agarwal K; Foster GR
    Lancet Gastroenterol Hepatol; 2019 Jan; 4(1):32-44. PubMed ID: 30477810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An SMS and animated video intervention to increase uptake of breast cancer screening: a randomised controlled trial.
    Acharya A; Darzi A; Judah G
    Lancet; 2023 Nov; 402 Suppl 1():S17. PubMed ID: 37997056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of a GP-endorsed 12 months' reminder letter to promote uptake of bowel scope screening: protocol for a randomised controlled trial in a hard-to-reach population.
    von Wagner C; Hirst Y; Tookey S; Kerrison RS; Marshall S; Prentice A; Vulkan D; Macleod U; Duffy S
    BMJ Open; 2018 May; 8(5):e022263. PubMed ID: 29730633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic obstructive pulmonary disease prevalence and prediction in a high-risk lung cancer screening population.
    Goffin JR; Pond GR; Puksa S; Tremblay A; Johnston M; Goss G; Nicholas G; Martel S; Bhatia R; Liu G; Schmidt H; Atkar-Khattra S; McWilliams A; Tsao MS; Tammemagi MC; Lam S
    BMC Pulm Med; 2020 Nov; 20(1):300. PubMed ID: 33198781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patient understanding and acceptability of an early lung cancer diagnosis trial: a qualitative study.
    Prout HC; Barham A; Bongard E; Tudor-Edwards R; Griffiths G; Hamilton W; Harrop E; Hood K; Hurt CN; Nelson R; Porter C; Roberts K; Rogers T; Thomas-Jones E; Tod A; Yeo ST; Neal RD; Nelson A
    Trials; 2018 Aug; 19(1):419. PubMed ID: 30075741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Co-development of an evidence-based personalised smoking cessation intervention for use in a lung cancer screening context.
    Quinn-Scoggins HD; Murray RL; Quaife SL; Smith P; Brain KE; Callister MEJ; Baldwin DR; Britton J; Crosbie PAJ; Thorley R; McCutchan GM
    BMC Pulm Med; 2022 Dec; 22(1):478. PubMed ID: 36522781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced invitation methods and uptake of health checks in primary care: randomised controlled trial and cohort study using electronic health records.
    McDermott L; Wright AJ; Cornelius V; Burgess C; Forster AS; Ashworth M; Khoshaba B; Clery P; Fuller F; Miller J; Dodhia H; Rudisill C; Conner MT; Gulliford MC
    Health Technol Assess; 2016 Nov; 20(84):1-92. PubMed ID: 27846927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of Protocol for Korean Lung Cancer Screening Project (K-LUCAS) to Evaluate Effectiveness and Feasibility to Implement National Cancer Screening Program.
    Lee J; Lim J; Kim Y; Kim HY; Goo JM; Lee CT; Jang SH; Lee WC; Lee CW; An JY; Ko KD; Lee MK; Choi KS; Park B; Lee DH
    Cancer Res Treat; 2019 Oct; 51(4):1285-1294. PubMed ID: 30776882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial.
    Paci E; Puliti D; Lopes Pegna A; Carrozzi L; Picozzi G; Falaschi F; Pistelli F; Aquilini F; Ocello C; Zappa M; Carozzi FM; Mascalchi M;
    Thorax; 2017 Sep; 72(9):825-831. PubMed ID: 28377492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-dose CT screening among never-smokers with or without a family history of lung cancer in Taiwan: a prospective cohort study.
    Chang GC; Chiu CH; Yu CJ; Chang YC; Chang YH; Hsu KH; Wu YC; Chen CY; Hsu HH; Wu MT; Yang CT; Chong IW; Lin YC; Hsia TC; Lin MC; Su WC; Lin CB; Lee KY; Wei YF; Lan GY; Chan WP; Wang KL; Wu MH; Tsai HH; Chian CF; Lai RS; Shih JY; Wang CL; Hsu JS; Chen KC; Chen CK; Hsia JY; Peng CK; Tang EK; Hsu CL; Chou TY; Shen WC; Tsai YH; Tsai CM; Chen YM; Lee YC; Chen HY; Yu SL; Chen CJ; Wan YL; Hsiung CA; Yang PC;
    Lancet Respir Med; 2024 Feb; 12(2):141-152. PubMed ID: 38042167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improving uptake in non-attenders of breast screening: selective use of second appointment.
    Stead MJ; Wallis MG; Wheaton ME
    J Med Screen; 1998; 5(2):69-72. PubMed ID: 9718524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A primary healthcare-based intervention to improve a Danish cervical cancer screening programme: a cluster randomised controlled trial.
    Jensen H; Svanholm H; Støvring H; Bro F
    J Epidemiol Community Health; 2009 Jul; 63(7):510-5. PubMed ID: 19228681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of an informed choice invitation on uptake of screening for diabetes in primary care (DICISION): trial protocol.
    Mann E; Prevost AT; Griffin S; Kellar I; Sutton S; Parker M; Sanderson S; Kinmonth AL; Marteau TM
    BMC Public Health; 2009 Feb; 9():63. PubMed ID: 19232112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluating the effectiveness of GP endorsement on increasing participation in the NHS Bowel Cancer Screening Programme in England: study protocol for a randomized controlled trial.
    Damery S; Smith S; Clements A; Holder R; Nichols L; Draper H; Clifford S; Parker L; Hobbs R; Wilson S
    Trials; 2012 Feb; 13():18. PubMed ID: 22348399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Artificial intelligence-supported screen reading versus standard double reading in the Mammography Screening with Artificial Intelligence trial (MASAI): a clinical safety analysis of a randomised, controlled, non-inferiority, single-blinded, screening accuracy study.
    Lång K; Josefsson V; Larsson AM; Larsson S; Högberg C; Sartor H; Hofvind S; Andersson I; Rosso A
    Lancet Oncol; 2023 Aug; 24(8):936-944. PubMed ID: 37541274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-dose computed tomography for lung cancer screening in high-risk populations: a systematic review and economic evaluation.
    Snowsill T; Yang H; Griffin E; Long L; Varley-Campbell J; Coelho H; Robinson S; Hyde C
    Health Technol Assess; 2018 Nov; 22(69):1-276. PubMed ID: 30518460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.